BioSpace News Archive

Clarius Mobile Health is first to introduce a third-generation product line of high-performance handheld wireless ultrasound scanners for all medical specialists.

According to Emergen Research, the global healthcare supply chain management market size was USD 2.19 billion in 2020 and is expected to reach USD 3.94 billion in 2028 and register a revenue CAGR of 7.6% during the forecast period, 2021-2028.

Aromyx, a leading company in applying biotechnology and data science to capture unique sensory data, announced that retail and Consumer Packaged Goods consumer insights expert, Elise Kern, has joined the company as SVP of Data and Insights.

The Preliminary Prospectus has not yet become final for the purpose of the sale of securities.

Firma Clinical Research promoted Jennifer Mintz to Chief Commercial Officer to oversee business development, marketing, contracts and proposals.

Increasing advancement in genomics research, rising adoption of sequencing techniques in clinical diagnostics, and growing investment in R&D in molecular biology and precision medicine are key factors driving market growth.

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) have entered into an agreement with Cosette Pharmaceuticals, Inc. whereby Daiichi Sankyo divested and Cosette acquired rights for manufacturing, commercialization, and certain other rights for the following products in the U.S.

Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that it has closed a transaction to acquire the US sales and distribution rights to eight branded commercial products from leading Japanese pharmaceutical company, Daiichi Sankyo Company, Ltd (4568:JP) and affiliates.

Leyden Laboratories B.V., announces the development of an intranasal spray protecting against influenza A and influenza B based on the human monoclonal antibody CR9114.